Nanologica AB (NICA) — Cash Flow-to-Debt Ratio
Nanologica AB (NICA) has a Cash Flow-to-Debt Ratio of -0.04x as of March 2026, meaning its operating cash flow of Skr-6.22 Million could theoretically repay 0% of its total liabilities (Skr164.82 Million) in one year. See Nanologica AB (NICA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nanologica AB Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Nanologica AB across 11 annual periods. For the full cash flow conversion analysis, see Nanologica AB (NICA) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Nanologica AB (2015–2025)
Year-by-year debt coverage analysis for Nanologica AB. Check Nanologica AB (NICA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.61x | Skr-39.88 Million | Skr65.47 Million | ▲ +47.9% |
| 2024 | -1.17x | Skr-80.73 Million | Skr68.99 Million | ▼ -159.0% |
| 2023 | -0.45x | Skr-35.85 Million | Skr79.33 Million | ▲ +18.7% |
| 2022 | -0.56x | Skr-45.22 Million | Skr81.36 Million | ▲ +44.1% |
| 2021 | -1.00x | Skr-46.49 Million | Skr46.72 Million | ▼ -22.6% |
| 2020 | -0.81x | Skr-43.34 Million | Skr53.38 Million | ▼ -168.9% |
| 2019 | -0.30x | Skr-11.52 Million | Skr38.16 Million | ▲ +72.6% |
| 2018 | -1.10x | Skr-11.71 Million | Skr10.62 Million | ▼ -13.9% |
| 2017 | -0.97x | Skr-23.19 Million | Skr23.98 Million | ▲ +59.0% |
| 2016 | -2.36x | Skr-23.19 Million | Skr9.84 Million | ▼ -45.8% |
| 2015 | -1.62x | Skr-13.95 Million | Skr8.63 Million | — |